These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2117418)

  • 21. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model.
    Gritz DC; McDonnell PJ; Lee TY; Tang-Liu D; Hubbard BB; Gwon A
    Cornea; 1992 Mar; 11(2):143-7. PubMed ID: 1582217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral ofloxacin therapy for invasive external otitis.
    Zikk D; Rapoport Y; Redianu C; Shalit I; Himmelfarb MZ
    Ann Otol Rhinol Laryngol; 1991 Aug; 100(8):632-7. PubMed ID: 1908200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals.
    Klesel N; Geweniger KH; Koletzki P; Isert D; Limbert M; Markus A; Riess G; Schramm H; Iyer P
    J Antimicrob Chemother; 1995 Jun; 35(6):805-19. PubMed ID: 7559192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice.
    Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
    Antimicrob Agents Chemother; 1997 Feb; 41(2):308-13. PubMed ID: 9021184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo antimicrobial activity of combined therapy of silver nanoparticles and visible blue light against Pseudomonas aeruginosa.
    Nour El Din S; El-Tayeb TA; Abou-Aisha K; El-Azizi M
    Int J Nanomedicine; 2016; 11():1749-58. PubMed ID: 27175075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival of irradiated mice treated with WR-151327, synthetic trehalose dicorynomycolate, or ofloxacin.
    Ledney GD; Elliott TB; Landauer MR; Vigneulle RM; Henderson PL; Harding RA; Tom SP
    Adv Space Res; 1994 Oct; 14(10):583-6. PubMed ID: 11539995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of in vitro susceptibilities to levofloxacin and ciprofloxacin with Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients in Northern Ireland.
    McKnight AJ; Shaw A; Goldsmith CE; Clarke L; Millar BC; McCaughan J; Elborn JS; Reid A; Moore JE
    Br J Biomed Sci; 2005; 62(1):30-2. PubMed ID: 15816210
    [No Abstract]   [Full Text] [Related]  

  • 29. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin.
    Yasuda H; Ajiki Y; Koga T; Kawada H; Yokota T
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1749-55. PubMed ID: 8239580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics.
    Lee EJ; Truong TN; Mendoza MN; Fleiszig SM
    Curr Eye Res; 2003 Nov; 27(5):289-99. PubMed ID: 14562165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Pseudomonas contamination or antibiotic decontamination of the GI tract on acute radiation lethality after neutron or gamma irradiation.
    Geraci JP; Jackson KL; Mariano MS
    Radiat Res; 1985 Dec; 104(3):395-405. PubMed ID: 3909210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
    Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2503-10. PubMed ID: 8585734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic resistance and biofilm formation in Pseudomonas aeruginosa strains isolated from patients with urinary tract infections].
    Cernohorská L; Sláviková P
    Epidemiol Mikrobiol Imunol; 2009 Nov; 58(4):154-7. PubMed ID: 21114003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible association of mucous blanket integrity with postirradiation colonization resistance.
    Walker RI; Brook I; Costerton JW; MacVittie T; Myhal ML
    Radiat Res; 1985 Dec; 104(3):346-57. PubMed ID: 3909209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Pexiganan Combination with Tigecycline in a Mouse Model of Pseudomonas aeruginosa Sepsis.
    Cirioni O; Simonetti O; Morroni G; Brescini L; Kamysz W; Kamysz E; Orlando F; Pierpaoli E; Caffarini M; Orciani M; Agostinelli C; Offidani A; Provinciali M; Giacometti A
    Curr Top Med Chem; 2018; 18(24):2127-2132. PubMed ID: 30569865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.
    Schito AM; Schito GC
    J Chemother; 2004 Apr; 16 Suppl 2():3-7. PubMed ID: 15255554
    [No Abstract]   [Full Text] [Related]  

  • 37. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
    Lee YJ; Liu HY; Lin YC; Sun KL; Chun CL; Hsueh PR
    Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study on topical and oral administration of ofloxacin for Pseudomonas corneal ulcer in rabbits.
    Shiao S; Isobe Y; Hatano H; Ohno S
    Ophthalmologica; 1995; 209(3):155-9. PubMed ID: 7630623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of High-Dose Meropenem (Six Grams per Day) in Treatment of Experimental Murine Pneumonia Induced by Meropenem-Resistant Pseudomonas aeruginosa.
    Oshima K; Nakamura S; Iwanaga N; Takemoto K; Miyazaki T; Yanagihara K; Miyazaki Y; Mukae H; Kohno S; Izumikawa K
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ofloxacin treatment of difficult infections of the skin and skin structure.
    Gentry LO; Rodriguez-Gomez G
    Cutis; 1993 Jan; 51(1):55-8. PubMed ID: 8419113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.